Perfusio, founded with a mission to revolutionize surgical procedures, offers FDA-approved, non-invasive surgical imaging solutions. Their core product, Certes™, utilizes patented technology to provide real-time visualization of perfusion and blood flow, enabling surgeons to make critical decisions with greater confidence. By allowing medical professionals to see beyond the visible light spectrum, Perfusio aims to improve patient outcomes and enhance the accuracy of surgical assessments.
Notable figures associated with Perfusio include Mike Dreiling, who plays a significant role in the company's operations. The company has achieved significant milestones, including FDA clearance for their innovative imaging device. Perfusio's impact is evident in its ability to transform surgical practices by providing immediate, real-time assessments of tissue integrity, ultimately aiming to improve surgical outcomes and patient care.
